News

Ensysce Biosciences, Inc (NASDAQ:ENSC) stock gained almost 100% with a strong session volume compared to the average volume ...
Sanfilippo syndrome is a rare genetic disorder that has been dubbed 'childhood Alzheimer's' because it causes children to ...
Applies TAAP and MPAR Technology to Produce Novel OUD Treatments ~ ~ Prioritizes Safety and Tolerability for OUD Patients ~ SAN DIEGO, CA / ACCESS Newswire / April 23, 2025 /Ensysce Biosciences, Inc.
Headquartered in Pleasanton, California, Boster Biological Technology is making waves in the research community with its ...
Below is a concise month-by-month overview of expected results from daily use of one Prime Biome gummy, based on its claims, ...
A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...
Scientists at Cincinnati Children's along with an international team of researchers have discovered a surprising new ...
Mineralys plans to provide additional data from the pivotal Phase 3 Launch-HTN at an upcoming medical conference and in a peer-reviewed publication. Additionally, the ongoing Transform-HTN open-label ...
Genome editing has progressed rapidly, showing promising outcomes for the treatment of genetic disorders, yet there remains ...
Regular physical activity, such as dance or targeted exercise, can slow the progression of Parkinson’s disease, helping ...
These hair aid products, which are in spray and serum formats, are not approved by the FDA but they are available via a ...